At a glance
ClinicalIndex Comparison RecordN/ACompleted· 142 enrolled
Drug / intervention
Ultrasound scandevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Data Collection for Next Generation Ultrasound Technology Development
In Brief
A clinical study evaluating Ultrasound scan for Endstage Renal Disease. Completed, enrolled 142 participants across 1 site.
Detailed Summary
The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndstage Renal Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedOct 2016
Primary CompletionDec 2016
TodayJul 2026
First PostedOct 27, 2016
Enrollment StartOct 26, 2016
Primary CompletionDec 6, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.7 years ago
Interventions
Ultrasound scandevice
Collection of ultrasound data sets that include routine ultrasound data (eg, extravascular lung fluid, cardiac velocity time integral and inferior vena cava) on the commercial GE Vivid S70 Ultrasound System which are used to test feasibility of next generation ultrasound algorithms being developed to process these data types.